These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1006719)

  • 1. Isolation and identification of a sulfur-containing metabolite of spironolactone from human urine.
    Koch K; Senn M; Steingross W
    Steroids; 1976 Oct; 28(4):467-80. PubMed ID: 1006719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and identification of novel impurities in spironolactone.
    Chen H; Wang YF; Yang ZD; Li YC
    J Pharm Biomed Anal; 2006 Mar; 40(5):1263-7. PubMed ID: 16242892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of metabolites of spironolactone by microbial oxygenation.
    Marsheck WJ; Karim A
    Appl Microbiol; 1973 Apr; 25(4):647-9. PubMed ID: 4699222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of spironolactone in man.
    Abshagen U; Rennekamp H; Luszpinski G
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):37-45. PubMed ID: 1012347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [THIN-LAYER CHROMATOGRAPHIC STUDIES OF 3'-(3-OXO-7-ALPHA-ACETYLTHIO-17-BETA-HYDROXY-4-ANDROSTEN-17-ALPHA-YL)-PROPIONIC ACID GAMMA-LACTONE AND ITS METABOLITES IN MAN].
    ZICHA L; WEIST F; SCHEIFFARTH ; SCHMID E
    Arzneimittelforschung; 1964 Jun; 14():699-705. PubMed ID: 14249070
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON THE METABOLISM OF 3-(3-OXO-7-ALPHA-ACETYLTHIO-17-BETA-HYDROXY-4-ANDROSTEN-17-ALPHA-YL)-PROPIONIC ACID-GAMMA-LACTONE].
    GERHARDS E; ENGELHARDT R
    Arzneimittelforschung; 1963 Nov; 13():972-7. PubMed ID: 14216044
    [No Abstract]   [Full Text] [Related]  

  • 7. Spironolactone metabolism in man studied by gas chromatography-mass spectrometry.
    Karim A; Hribar J; Aksamit W; Doherty M; Chinn LJ
    Drug Metab Dispos; 1975; 3(6):467-78. PubMed ID: 1221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence assessment of two formulations of spironolactone in Chinese healthy male volunteers.
    Xu FG; Zhang ZJ; Dong HJ; Tian Y; Liu Y; Chen Y
    Arzneimittelforschung; 2008; 58(3):117-21. PubMed ID: 18488807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and identification of novel sulfur-containing metabolites of spironolactone (Aldactone).
    Karim A; Brown EA
    Steroids; 1972 Jul; 20(1):41-62. PubMed ID: 5042701
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and Physicochemical Characterization of the Process-Related Impurities of Eplerenone, an Antihypertensive Drug.
    Dams I; Białońska A; Cmoch P; Krupa M; Pietraszek A; Ostaszewska A; Chodyński M
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28809817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective synthesis of the two major metabolites of spironolactone, 3alpha- and 3beta-hydroxy-7alpha-methylthio-17alpha-pregn-4-ene-21,17-carbolactone.
    Li G; Zhang Y
    Steroids; 2007 Jun; 72(6-7):569-72. PubMed ID: 17493649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the effects of alfathesin and other steroid anesthetics by catatoxic steroids in rats.
    Taché Y; Taché J; Selye H
    Arzneimittelforschung; 1975 Oct; 25(10):1603-6. PubMed ID: 54171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of a new antialdosterone compound, prorenone.
    Claire M; Rafestin-Oblin ME; Michaud A; Roth-Meyer C; Corvol P
    Endocrinology; 1979 Apr; 104(4):1194-200. PubMed ID: 436757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic studies and bioavailability of bendroflumethiazide in combination with spironolactone].
    Vergin H; Nuss U; Strobel K
    Arzneimittelforschung; 1986 Mar; 36(3):490-5. PubMed ID: 3707669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of two aldosterone antagonists on cat perfused kidneys.
    LOCKETT MF; ROBERTS CN
    Br J Pharmacol Chemother; 1963 Jun; 20(3):443-8. PubMed ID: 13931194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel spironolactone-analogs as impurities in spironolactone.
    Chen H; Wang XY; Yang ZD; Li YC
    Steroids; 2004 Sep; 69(10):647-52. PubMed ID: 15465109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial metabolism of danazol: a contribution to doping analysis.
    Marzouk AM; Maatooq GT
    Z Naturforsch C J Biosci; 2014; 69(5-6):245-52. PubMed ID: 25069163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3- (16Beta,17beta-dihydroxy-3-oxoandrost-4-en-17alpha-yl) propionic acid gamma-lactone, its preparation and antimineralocorticoid activity.
    Chinn LJ; Hofmann LM
    J Med Chem; 1973 Jul; 16(7):839-43. PubMed ID: 4725930
    [No Abstract]   [Full Text] [Related]  

  • 19. Separation of spironolactone and its biologically active sulfur-containing metabolites by high-performance liquid chromatography.
    Sherry JH; O'Donnell JP; Colby HD
    J Chromatogr; 1986 Jan; 374(1):183-90. PubMed ID: 3949927
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.